Companies in #Graves' Disease

Found 2 companies operating in this sector.

Ethyreal

Private

Ethyreal is a private clinical-stage biotechnology company developing antibody-based therapies for autoimmune endocrine disorders, with a focus on Graves' disease and the related thyroid eye disease (TED). Its lead candidate selectively targets the IGF-1 receptor pathway in orbital fibroblasts.

Sector:Biotechnology / Autoimmune

HQ:South San Francisco, California, USA

View Profile →

Yarrow Bioscience

Private

Clinical-stage biotech developing monoclonal antibody therapies for autoimmune thyroid diseases (Graves' disease, thyroid eye disease). Lead candidate YB-101 targets TSHR receptor.

Sector:Biotechnology

HQ:United States

View Profile →